Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699645010 | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699647019 | Drospirenone 3 mg and ethinylestradiol 30 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699648012 | Drospirenone 3 mg and ethinyl estradiol 30 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4722361000005113 | drospirenon 3 mg + ethynylestradiol 0,03 mg tablet | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | dansk modul |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing ethinylestradiol (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Estradiol | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing drospirenone (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Drospirenone (substance) | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing drospirenone and ethinylestradiol (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Progesterone | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing estradiol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.03 | false | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | en | false | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Drospirenone (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Drospirenone (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | tre | false | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | en | false | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Drospirenone (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | tre | false | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ethinylestradiol | false | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Drospirenone (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ethinylestradiol | false | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | to | false | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | false | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 30 | false | Inferred relationship | Some | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Plays role | Contraceptive therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Drospirenone (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR